RVMD Revolution Medicines
- 38.170
- -0.140-0.37%
Revolution Medicines News
Revolution Medicines Is Maintained at Outperform by Wedbush
Revolution Medicines Is Maintained at Outperform by Wedbush
Revolution Medicines Price Target Raised to $46.00/Share From $42.00 by Wedbush
Revolution Medicines Price Target Raised to $46.00/Share From $42.00 by Wedbush
J.P. Morgan Sticks to Its Buy Rating for Revolution Medicines (RVMD)
Needham Reiterates Buy on Revolution Medicines, Maintains $46 Price Target
Needham analyst Ami Fadia reiterates Revolution Medicines with a Buy and maintains $46 price target.
Revolution Medicines Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 20.07% Needham → $46 Reiterates Buy → Buy 04/12/2024 17.46% Oppenheimer $43 → $45 Maintains Out
Revolution Medicines Inc (RVMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Revolution Medicines, Inc. (RVMD) Q1 2024 Earnings Call Transcript
Revolution Medicines, Inc. (RVMD) Q1 2024 Earnings Call Transcript
Revolution Medicines Q1 2024 GAAP EPS $(0.70) Beats $(0.75) Estimate
Revolution Medicines (NASDAQ:RVMD) reported quarterly losses of $(0.70) per share which beat the analyst consensus estimate of $(0.75) by 6.67 percent.
Revolution Medicines Q1 Net Loss Narrows
Revolution Medicines (RVMD) reported a Q1 net loss Wednesday of $0.70 per share, narrowing from a loss of $0.72 a year earlier. Analysts polled by Capital IQ expected a loss of $0.75. The company did
Revolution Medicines Reiterates Projected Full Year 2024 GAAP Net Loss To Be $(480)M-$(520)M
Based on the company's current operating plan, the company projects current cash, cash equivalents and marketable securities can fund planned operations into 2027.
10-Q: Quarterly report
Press Release: Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., May 08,
Revolution Medicines 1Q Loss/Shr 70c >RVMD
Revolution Medicines 1Q Loss/Shr 70c >RVMD
Insider Sale: CFO Jack Anders Sells 10,000 Shares of Revolution Medicines Inc (RVMD)
Revolution Medicines(RVMD.US) Officer Sells US$400.26K in Common Stock
$Revolution Medicines(RVMD.US)$ Officer Anders Jack sold 10,000 shares of common stock on May 3, 2024 at an average price of $40.026 for a total value of $400.26K.Source: Announcement What is statemen
S&P 500 Futures Decline In Premarket Trading; Paramount Global, Revolution Medicines Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Paramount Global Cl B (PARA) was up 9.6% in pre-mar
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Revolution Medicines (RVMD)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intuitive Surgical (ISRG) and Revolution Medicines (RVMD) with bullish sentiments.
Revolution Medicines(RVMD.US) Officer Sells US$619.47K in Common Stock
$Revolution Medicines(RVMD.US)$ Officer GOLDSMITH MARK A sold 17,500 shares of common stock on Apr 10, 2024 at an average price of $35.3981 for a total value of $619.47K.Source: Announcement What is s
Revolution Medicines(RVMD.US) Director Sells US$79,735 in Common Stock
$Revolution Medicines(RVMD.US)$ Director Patel Sushil sold 2,155 shares of common stock on Apr 10, 2024 at an average price of $37 for a total value of $79,735.Source: Announcement What is statement o
Top 10 Stocks With Upwards and Downwards Daily Percentage Change - Piper Sandler
Analysis
Price Target
No Data
